Today, cancer is no longer on the list of incurable diseases, thanks to medical developments in the last few decades. Yet, it is hard to ignore the fact that cancer does alter the lives of patients. We know of many adults that have undergone not just physical but an emotional overhaul during their cancer journey - some of them returning to life with an altered perspective and unending empathy for people around them after having been through the trials and trauma of chemotherapy and radiation.
For children, it might be a totally different story. For many of them, the effects of cancer treatment do not begin until later in life resulting in other health concerns. In fact, studying these late effects is the research focus of many medical researchers in the field of pediatric cancer. Many of these effects are the result of how chemotherapy works - in order to kills the cancerous cells, it destroys a good number of healthy cells as collateral damage.
I recently spoke with Dr. Ramesh Rengan, medical director of Seattle Cancer Care Alliance (SCCA) Proton Therapy Center in Seattle, Washington, and a long-term researcher in the field of novel radiation approaches with immune therapies in the treatment of cancer. Dr. Rengan is an active voice for proton therapy emerging as an increasingly effective and less harmful way to treat specific types of cancers, particularly pediatric cancers and those that occur close to vital organs.
Here are a few excerpts from our interview:
The SCCA Proton center works on an alternative treatment method for cancer. Can you tell us more about it?
At the SCCA Proton Therapy Center, we use highly targeted proton beam radiation to treat cancer. By precisely focusing on the tumor, proton therapy minimizes radiation exposure to surrounding healthy tissue, thereby reducing the risk of short- and long-term radiation-related side effects. Our center is currently the only proton therapy center in the Pacific Northwest.
How does proton therapy work?
The fundamental concept underlying all cancer treatment is to deliver a lethally effective treatment to the cancer and only the cancer, be it chemotherapy, surgery or radiation. The challenge for the oncologist is to design a way to deliver this treatment with specificity to the tumor while minimizing the damage to the surrounding organs. What really dictates the long-term clinical outcome for the patient is not just the number of cancer cells that we kill but the balance between that and the number of healthy cells that are injured in the course of treatment.
Standard radiation uses X-ray beams that enter and pass through the patient to the tumor and exit the other side. However, because X-rays penetrate so well, all tissue that lies in front of and beyond the tumor is exposed to radiation, which can be potentially harmful to the patient.
Protons, due to their mass, stop within the patient and do not continue to pass through the body. We can therefore calibrate the proton beam to stop within the tumor itself. Additionally, due to their positive charge, protons deposit most of their radiation at the point where they stop, rather than near the point of entry into the patient as X-rays do. As a result of these properties, protons concentrate the radiation dose delivery to the tumor itself. This more targeted form of radiation is especially useful for pediatric cancers, where any excess radiation exposure to healthy, developing organs can be potentially harmful.
What are the benefits of proton therapy over other types of cancer treatments?
Protons allow radiation to be delivered to the tumor while significantly minimizing collateral radiation exposure to surrounding healthy tissue. That benefit pays dividends in the near term because it reduces exposure, and it drives additional future benefits as patients continue with their lives after treatment, such as fewer secondary cancers. The precision that protons allow is particularly beneficial for patients whose tumors are near critical organs or structures, such as the brain, bladder, rectum, heart or spinal cord; patients whose cancers have recurred after initial radiation treatment; and patients whose organs are particularly sensitive to radiation exposure, such as children and adults with certain genetic syndromes.
For what kind of cancers is the proton therapy most effective ?
Although protons can be used to treat most cancers that require radiation, this treatment has been best established for tumors that lie in close proximity to radiosensitive vital organs, such as central nervous system tumors and eye tumors. For pediatric patients, protons have become an indispensable tool, as children are particularly vulnerable to the negative effects of radiation. Therefore, proton treatment for many pediatric tumors is a well-established standard of care, despite the limited access to proton therapy centers worldwide. Today, we also treat tumors in the head and neck, lung, breast, esophagus and gastrointestinal system, as these tumors are often situated next to radiosensitive vital organs. As such, the role of protons is being actively investigated in ongoing clinical trials in these disease locations.
Are protons a stand-alone treatment, or is it best used in conjunction with other therapies?
Proton therapy can often be used in combination with chemotherapy and surgery, similar to standard radiation treatment.
How is proton therapy improving?
Access to clinics, lowered cost, optimized technology to treat a broader range of tumors and use of a combination of approaches to treatment are the biggest recent leaps we have made with proton treatment.
Its important to understand that protons initially were postulated in the treatment of cancer in a paper published in 1946. Protons are not new as a modality, having been around since the 1950s. It has taken a long time for the technology to become relatively cost-efficient and be feasibly delivered in a hospital-based or stand-alone outpatient clinical setting such as the Seattle Cancer Care Alliance Proton Therapy Center.
Growth has been deliberate and incremental: the first hospital-based proton center opened in the 90s. Today there are 20 proton centers in North America, but the real promise of proton treatment is being realized now. During the next 10 years, we expect to see that number triple or quadruple, as the cost of building a center has been rapidly decreasing while proton beam technology has been simultaneously improving.
Are protons the best choice for everyone?
Protons are just as effective as X-rays in killing cancer cells but generally require less exposure to surrounding healthy tissues in order to deliver this treatment to the cancer, so they are a potential option whenever radiation is called for in the curative treatment of cancer. However, protons are only a single tool in the ever-increasing arsenal against cancer. As such, protons are the best treatment for some patients, but not for others. The decision regarding whether protons are the right choice for a given patient is made by a proton-experienced radiation oncologist in conjunction with members of the multidisciplinary cancer care team and the patient.
What do you believe are the next big revolutions in cancer treatments?
The big revolution in cancer treatment will come from our increasing ability to deliver effective therapies to the tumor with absolute specificity. For example, that is the founding principle behind cancer immunotherapy, namely, to turn our immune system against the cancer. Similarly, the greater our ability to focus our radiation beam or our scalpels at purely the cancer and minimize the impact to the surrounding organs, the greater the benefit to our patients.
In the past few years we have made fundamental paradigm shifts in the way we treat cancer. Today we attack cancer by exploiting the unique genetic characteristics of the tumor to design drugs that attack the cancer by homing in on their gene signature. Even with these modern advancements, it must be mentioned that cancer is not just treated with one method alone; a combination of weapons is used to effectively cure most cancers. One might say that it takes a village to effectively treat a cancer patient.
Much of the early history of cancer treatment had focused on maximizing the lethality of our weapons against the cancer, either by increasing the radiation or chemotherapy dose or by performing larger and more radical surgery to remove the tumor. We now recognize that the impact of these treatments on healthy tissue can have an even greater negative effect on the clinical outcome than the positive benefit of killing the tumor. In short, we dont need a bigger gun or bomb, but rather a smarter bomb that equally emphasizes supporting the health of the patient and the destruction of the cancer. Protons are ideally suited to this evolution in cancer care.
Devishobhais the founder ofKidskintha,a happy place to jumpstart conversations around family and millennial parenting, living in India. You can find her voiceon the Huffington Post,LifeHack, Parent.co,Addicted2Success, Inc.com, Entrepreneur, Tiny Buddha,SivanaEast and others on a range of topics. You can get yourself equipped for happy parenting with one hack a week for an entire year (each one backed by science).
The Morning Email
Wake up to the day's most important news.
- The Patient Perspective On Patient Centricity Insights From A Veteran Of 5 Clinical Trials - Clinical Leader - October 12th, 2019
- Parkinsons Disease Treatment Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2025 - The Ukiah Post - October 11th, 2019
- Transfusion-dependent Anemia Treatment Market Gain Impetus due to the Growing Demand over 2019 2029 - Herald Space - October 1st, 2019
- Non-viral Gene Therapy will now accelerate cancer study - Industry Reporter - September 28th, 2019
- Social Impact Heroes: How Lynn OConnor Vos and the Muscular Dystrophy Association are helping to raise billions of dollars to fund research to... - September 28th, 2019
- Pollard and Norris in the race for Pos. 2 of the Public Hospital District 4 - Snoqualmie Valley Record - September 28th, 2019
- Nearly Half of Poland's SMA Patients on Track to Get Spinraza, Experts Say - SMA News Today - September 28th, 2019
- Prospective Study Characterizes PCa Risk Linked to BRCA1, BRCA2 Mutations - Renal and Urology News - September 28th, 2019
- Precision Cancer Therapies Market Forecast Research Reports Offers Key Insights 2017 2025 - Space Market Research - September 28th, 2019
- Google bans ads for 'bad actors' selling 'deceptive treatments' - BioEdge - September 22nd, 2019
- Texas State To Expand Round Rock Campus Programs, Services - Round Rock, TX Patch - September 22nd, 2019
- Transfusion-dependent Anemia Treatment Market Size, Status and Growth Opportunities by 2025 - The Market Plan - September 22nd, 2019
- Chemotherapy Drugs Market Strategies, Major Industry Participants, Marketing Channels and Forecast To2018 2028 - Commerce Gazette - September 22nd, 2019
- Targeted Cancer Therapies Market Regional Landscape, Production, Sales & Consumption Status and Prospects 2025 - Commerce Gazette - September 22nd, 2019
- Precision Cancer Therapies Market to Witness Comprehensive Growth by 2017 2025 - Technology Trend - September 22nd, 2019
- Biological Product Manufacturing Market Analysis, Size, Regional Outlook, Share, Trend, Growth, Analysis and Forecast - Rapid News Network - September 22nd, 2019
- Google Bans Advertising on Unproven Medical Treatments (like Stem Cells) - Bedford Bulletin - September 22nd, 2019
- 4 Barriers To Cell And Gene Therapy Development For Rare ... - May 18th, 2019
- Gene Therapy: The New Frontier for Inherited Retinal Disease - April 16th, 2019
- Nutrition : The Addiction Recovery Guide - March 25th, 2019
- F.D.A. Speeds Review of Gene Therapies, Vowing to Target ... - February 17th, 2019
- Cell and Gene Therapy Center - IQVIA - December 24th, 2018
- resurrection-clinics.eu - August 24th, 2018
- Hacking Your Genes Has Never Been Easier - Outside Magazine - September 8th, 2017
- FDA approves first cell-based gene therapy for use in the United States - Gears Of Biz - September 8th, 2017
- Quick Hits: Withdrawn Leukemia Drug Returning, Drugmaker in $58M Settlement Over Sales Reps, and More - MedShadow (registration) (blog) - September 8th, 2017
- FDA Approves New Cancer Treatment - Alive For Football - September 5th, 2017
- Global Cancer Biological Therapy Analysis & Forecast 2016 to 2023 - Digital Journal - September 5th, 2017
- How one California county is fighting high-priced surgeries - Los Angeles Times - September 2nd, 2017
- New 'hit-and-run' gene editing tool temporarily rewrites genetics to treat cancer and HIV - GeekWire - September 2nd, 2017
- Australian Market Declines - Markets Insider - August 29th, 2017
- New Stanford drug saves child with deadly genetic disease - The Mercury News - August 25th, 2017
- Orphan Diseases Market Key Players analysis ... - Digital Journal - Digital Journal - August 25th, 2017
- Gene Editing in Human Embryos Leaps ForwardHere's the Science - Singularity Hub - August 22nd, 2017
- Global Cancer Biological Therapy Market 2017 Size, Development Status, Type and Application, Segmentation ... - Digital Journal - August 22nd, 2017
- Traditional Therapy Clinics Ltd (TTC.AX) Money Flow Index Levels in Focus - Stock Daily Review - August 22nd, 2017
- Sodium Iodide Symporter for Nuclear Molecular Imaging and ... - August 13th, 2017
- Biological bypass shows promise in coronary artery disease - Medical Xpress - August 12th, 2017
- Cardiovascular disease cure? One session of THIS could help treat condition - Express.co.uk - August 9th, 2017
- Understanding the muscle behind global duchenne muscular dystrophy market - WhaTech - August 9th, 2017
- Wilson's Disease Market: Unmet Needs of Patient Population to Inspire Players for Improved Treatment Options - Edition Truth - August 5th, 2017
- In a first, scientists edit fatal gene mutation out of DNA - Asheboro Courier Tribune - August 4th, 2017
- Head and Neck Cancer Therapeutics Market is Expected to Generate Huge Profits by 2024 - MilTech - July 12th, 2017
- Cancer Biological Therapy market is rising with potential rate at CAGR of 4.7 % till 2023 - MENAFN.COM - July 11th, 2017
- Stem cell therapies breaking barriers - Guardian (blog) - July 9th, 2017
- Alternative Cancer Clinics - Immunotherapy for Cancer - July 8th, 2017
- Advanced Gene-Targeted Therapies - Alternative Cancer Clinics - July 8th, 2017
- Cure for ageing could lie in gene therapy | WIRED UK - July 1st, 2017
- Digital Journal: A Global Digital Media Network - Digital Journal (press release) - July 1st, 2017
- Gene Therapy Market - Size, Share, industry, Forecast ... - November 30th, 2016
- Medi-Cal: Medi-Cal Update - Clinics and Hospitals | May ... - November 23rd, 2016
- Gene Therapy: Chinese Researching Gene Replacement - September 25th, 2015
- Home Page of the Human Gene and Cell Therapy Center - August 29th, 2015